Interpace Biosciences Inc (IDXG)

OTC Markets

Currency in USD

2.0230

+0.0255(+1.28%)

Closed·15:32:27

Fair Value

Unlock Value

Day's Range

1.9000

2.0230

52 wk Range

0.4433

2.4000

IDXG Income Statement

Assess the Interpace Biosciences income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the IDXG net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

33.12

31.84

40.04

46.93

38.73

Total Revenues Growth

aa.aa

+2.22%

-3.86%

+25.75%

+17.21%

-17.47%

Cost Of Revenues

aa.aa

14.31

13.61

14.98

14.6

Gross Profit

aa.aa

18.8

18.23

25.06

29.93

24.13

Gross Profit Growth

aa.aa

+75.32%

-3.04%

+37.44%

+19.43%

-19.37%

Gross Profit Margin %

aa.aa

56.78%

57.26%

62.58%

63.77%

62.31%

Other Operating Expenses, Total

aa.aa

24.57

22.07

21.09

21.82

19.35

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-29.21%	-10.16%	-4.43%	+3.43%	-11.33%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1.49	0.7	0.64	0.68	0.64
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	19.88	20.1	19.6	21.14	18.7
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

-5.76

-3.84

3.96

8.11

4.78

Operating Income Growth

aa.aa

+75.96%

+33.38%

+203.2%

+104.59%

-41%

EBIT Margin %

aa.aa

-17.4%

-12.06%

9.9%

17.28%

12.35%

Net Interest Expenses

aa.aa

-1.04

-1.01

-0.66

-0.17

Net Interest Expenses Growth

aa.aa

-89.44%

+3.08%

+34.62%

+74.51%

Interest Expense, Total

aa.aa

-1.04

-1.01

-0.66

-0.17

Interest And Investment Income

aa.aa

Other Non Operating Expenses, Total

aa.aa

-0.38

-1.21

-0.67

-0.5

-0.14

EBT, Excl. Unusual Items

aa.aa

-7.18

-6.06

2.29

6.95

4.47

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

0.34

0.22

-0.01

EBT, Incl. Unusual Items

aa.aa

-7.74

-5.84

2.28

6.95

3.77

EBT, Incl. Unusual Items Growth

aa.aa

+70.39%

+24.62%

+139.08%

+204.69%

-45.7%

EBT, Incl. Unusual Items Margin

aa.aa

-23.38%

-18.33%

5.7%

14.81%

9.74%

Income Tax Expense

aa.aa

-0.71

0.03

0.02

-21.21

Net Income to Company

aa.aa

-14.94

-21.96

1.95

6.7

24.58

Minority Interest

aa.aa

Net Income

aa.aa

-14.94

-21.96

1.95

6.7

24.58

Net Income Growth

aa.aa

+43.51%

-46.95%

+108.9%

+242.99%

+266.68%

Net Income Margin %

aa.aa

-45.12%

-68.97%

4.88%

14.28%

63.46%

Preferred Dividend and Other Adjustments

aa.aa

0.46

Net Income to Common Excl. Extra Items

aa.aa

-7.04

-5.87

2.26

6.48

24.98

Basic EPS - Continuing Operations

aa.aa

-1.7

-1.38

0.52

1.48

5.65

Basic EPS - Continuing Operations Growth

aa.aa

+76.55%

+18.68%

+137.9%

+181.74%

+282.21%

Diluted EPS - Continuing Operations

aa.aa

-1.7

-1.38

0.52

1.41

0.9

Diluted EPS - Continuing Operations Growth

aa.aa

+76.56%

+18.68%

+137.57%

+171.15%

-36.17%

Basic Weighted Average Shares Outstanding

aa.aa

4.14

4.24

4.32

4.39

4.42

Diluted Weighted Average Shares Outstanding

aa.aa

4.14

4.24

4.36

15.73

27.7

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-0.39

-1.28

4.99

8.41

5.21

EBITDA Growth

aa.aa

+97.89%

-228.21%

+489.77%

+68.53%

-38.05%

EBITDA Margin %

aa.aa

-1.18%

-4.02%

12.46%

17.92%

13.45%

EBIT

aa.aa

-5.76

-3.84

3.96

8.11

4.78

* In Millions of USD (except for per share items)

FAQ

What was Interpace Biosciences’s revenue at year end?

At the end of the last reported fiscal year, Interpace Biosciences (IDXG) recorded total revenue of 38.7280 million USD.

How much revenue did Interpace Biosciences report in the most recent quarter?

In its most recent quarterly earnings report, Interpace Biosciences posted revenue of 9.2240 million USD.

What was Interpace Biosciences’s net income for the year?

For the full year, Interpace Biosciences reported net income of 24.5750 million USD.

How much net income did Interpace Biosciences post in the last quarter?

In the most recent quarter, Interpace Biosciences (IDXG) posted net income of 22.6570 million USD.

What was Interpace Biosciences’s gross profit for the year?

Gross profit for the year was reported at 24.1300 million USD.

How much gross profit did Interpace Biosciences generate last quarter?

Interpace Biosciences recorded gross profit of 6.0440 million USD in its latest quarterly report.

What was Interpace Biosciences’s annual operating income?

For the full year, Interpace Biosciences (IDXG) reported operating income of 4.7840 million USD.

What was Interpace Biosciences’s operating income last quarter?

Quarterly operating income was 2.2770 million USD.

What was Interpace Biosciences’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 2.3950 million USD.

What was the quarter-over-quarter change in EBITDA for Interpace Biosciences?

EBITDA changed by 90.6847% million USD compared to the last quarter.

What is Interpace Biosciences’s most recent gross profit margin?

The latest reported gross profit margin for Interpace Biosciences (IDXG) is 65.5247% million USD.

What is Interpace Biosciences’s most recent net income margin?

Net income margin based on recent financials is 245.6309% million USD.

What is Interpace Biosciences’s most recent EBIT margin?

Interpace Biosciences reported an EBIT margin of 24.6856% million USD based on current figures.

How did Interpace Biosciences’s revenue change compared to the previous quarter?

Revenue changed by 5.3449% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Interpace Biosciences?

In the latest quarter, gross profit changed by 11.1234% million USD from the previous quarter.

S&P/TSX

33,912.93

-42.18

-0.12%

S&P/TSX 60

1,975.86

-0.87

-0.04%

US 30

49,260.50

-48.8

-0.10%

US 500

7,113.10

+4.8

+0.07%

S&P 500 VIX

19.31

+0.39

+2.06%

DAX

24,155.45

-39.45

-0.16%

Dollar Index

98.66

+0.240

+0.25%

Market Movers

Name	Last	Chg. %	Vol.
TC Energy	83.43	+1.60%	8.25M
Enbridge	71.91	+1.48%	7.95M
Canadian Natural	62.21	+1.80%	7.17M
Bank of Montreal	207.66	+0.63%	4.66M
Suncor Energy	88.48	+2.03%	3.43M
Toronto Dominion Bank	143.82	+0.62%	3.41M
RBC	239.56	-0.03%	3.39M

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.04	+700.00%	11.33K
PeakBirch Logic	0.030	+500.00%	1.32K
Irwin Naturals	0.30	+150.00%	3.24K
Global Health Clinics	0.070	+133.33%	5.00K
MX Gold Corp	0.0450	+125.00%	6.65K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Spod Lithium	0.01	+100.00%	2.64K

Name	Last	Chg. %	Vol.
New Frontier Ventures	0.030	-68.42%	13.00K
Noble Iron	0.0100	-66.67%	81.52K
Mayfair Acquisition	0.02	-60.00%	23.00K
CordovaCann	0.0150	-57.14%	22.00K
Portofino Resources	0.0050	-50.00%	22.84K
Molecule Holdings	0.005	-50.00%	20.11K
Albert Labs International	0.005	-50.00%	1.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Canopy Growth	1.650	-12.70%	13.13M
Air Canada	18.26	-0.16%	2.50M
Celestica Inc.	537.48	-2.24%	503.24K
Hut 8	108.010	-2.13%	891.37K
Canadian Natural	62.21	+1.80%	7.17M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaa Aaaaaaaa Aaa	5.18	+61.02%	8.34
Aaaaa Aa Aa Aa	43.34	+51.02%	65.45
Aaa Aaaa	100.04	+49.29%	149.35
Aaaaaaaaaa Aaaaaaaa	23.06	+42.56%	32.87
Aaaaaaaaa	6.78	+41.97%	9.63
Aaaa Aaaaaa Aaaaaa	258.80	+40.34%	363.20
Aaaaa Aaaaaaaaaa A	10.72	+40.07%	15.02

Name	Last	Upside	Fair Value
Aaaaa Aaaaaaaa Aaa	5.18	+61.02%	8.34
Aaaaa Aa Aa Aa	43.34	+51.02%	65.45
Aaa Aaaa	100.04	+49.29%	149.35
Aaaaaaaaaa Aaaaaaaa	23.06	+42.56%	32.87
Aaaaaaaaa	6.78	+41.97%	9.63
Aaaa Aaaaaa Aaaaaa	258.80	+40.34%	363.20
Aaaaa Aaaaaaaaaa A	10.72	+40.07%	15.02

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Interpace Biosciences Inc (IDXG)

IDXG Income Statement

FAQ

What was Interpace Biosciences’s revenue at year end?

How much revenue did Interpace Biosciences report in the most recent quarter?

What was Interpace Biosciences’s net income for the year?

How much net income did Interpace Biosciences post in the last quarter?

What was Interpace Biosciences’s gross profit for the year?

How much gross profit did Interpace Biosciences generate last quarter?

What was Interpace Biosciences’s annual operating income?

What was Interpace Biosciences’s operating income last quarter?

What was Interpace Biosciences’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Interpace Biosciences?

What is Interpace Biosciences’s most recent gross profit margin?

What is Interpace Biosciences’s most recent net income margin?

What is Interpace Biosciences’s most recent EBIT margin?

How did Interpace Biosciences’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Interpace Biosciences?

Trending Stocks